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Context
• The urinary reconstructive options available after radical
cystectomy (RC) for bladder cancer are discussed, as are the
criteria for selection of the most appropriate diversion, and
the outcomes and complications associated with diﬀerent
diversion options.
Objective
• To critically review the peer-reviewed literature on the
function and oncological outcomes, complications, and
factors inﬂuencing choice of procedure with urinary
diversion after RC for bladder carcinoma.
Evidence Acquisition
• A Medline search was conducted to identify original
articles, review articles, and editorials on urinary diversion
in patients treated with RC. Searches were limited to the
English language.
• Keywords included: ‘bladder cancer’, ‘cystectomy’, ‘diversion’,
‘neobladder’, and ‘conduit’.
• The articles with the highest level of evidence were selected
and reviewed, with the consensus of all of the authors of
this paper.
Evidence Synthesis
• Both continent and incontinent diversions are available for
urinary reconstruction after RC. In appropriately selected
patients, an orthotopic neobladder permits the elimination
of an external stoma and preservation of body image
without compromising cancer control. However, the
patient must be fully educated and committed to the
labour-intensive rehabilitation process. He must also be able
to perform self-catheterisation if necessary.
• When involvement of the urinary outﬂow tract by tumour
prevents the use of an orthotopic neobladder, a continent
cutaneous reservoir may still oﬀer the opportunity
for continence albeit one that requires obligate
self-catheterisation.
• For patients who are not candidates for continent diversion,
the ileal loop remains an acceptable and reliable option.
Conclusions
• Both continent and incontinent diversions are available for
urinary reconstruction after RC.
• Orthotopic neobladders optimally preserve body image,
while continent cutaneous diversions represent a reasonable
alternative.
• Ileal conduits represent the fastest, easiest, least
complication-prone, and most commonly performed
urinary diversion.
Keywords
bladder cancer, outcome assessment (health care), patient
selection, radical cystectomy, urinary bladder neoplasms,
urinary diversion
© 2013 BJU International | doi:10.1111/bju.12121 BJU Int 2014; 113: 11–23
Published by John Wiley & Sons Ltd. www.bjui.org wileyonlinelibrary.com
Reviews
Introduction
Radical cystectomy (RC) for bladder cancer requires
reconstruction of the lower urinary tract. Ureterosigmoidostomy
was the ﬁrst widely used surgical technique for urinary diversion,
providing an eﬀective diversion using the anal sphincter for
continence. However, deterioration of renal function over time,
metabolic complications, and the increased risk for secondary
malignancies limited its usefulness as a urinary diversion.
Subsequent surgical advances have led to major improvements in
both functional outcomes and health-related quality of life
(HRQOL).We discuss the available reconstructive options after
RC for bladder cancer, criteria for selection, and the outcomes
associated with each option.
Evidence Acquisition
A Medline search was conducted to identify original English
language articles on urinary diversion after RC using the
keywords ‘bladder cancer’, ‘cystectomy’, ‘diversion’,
‘neobladder’, and ‘conduit’. In all, 105 articles were identiﬁed
and those with the highest level of evidence were selected
and reviewed. Reviews and other secondary data sources
were excluded.
Evidence Synthesis
Depending on the segment of bowel used to create a urinary
diversion, speciﬁc metabolic consequences may ensue, as
outlined in Table 1. Postoperative bowel function may also be
altered. The ideal urinary diversion has yet to be developed
(Table 2). Currently, urinary reconstruction falls into two
general categories: incontinent diversions, such as the ileal
conduit, and continent diversions, including both cutaneous
reservoirs and orthotopic reservoirs connected to the urethra.
Ureterosigmoidostomy
One of the ﬁrst urinary diversions using bowel included the
use of ureterosigmoidostomy, where the ureters were
anastomosed to the sigmoid. Its major advantage is the
potential for spontaneous emptying of urine with stool, i.e.
continence is maintained by the anal sphincter.
Table 1 Primary indications and metabolic consequences for use of bowel segments.
Bowel segment Primary indication Metabolic consequences Clinical symptoms
Gastric • Children requiring diversion (exstrophy, pelvic
radiation)
• Renal insuﬃciency
Metabolic alkalosis (↓ K and Cl,
hypergastrinaemia)
• Haematuria-dysuria syndrome
• Dehydration, lethargy, seizures, respiratory
distress
Jejunum • Pelvic radiation
• Deﬁcient ureteric length
• Compromised viability of other small or large
bowel
Metabolic acidosis (↓ Na and Cl, ↑ K,
azotaemia)
• Dehydration, nausea/vomiting, weakness,
lethargy, seizures
Ileum or ileal-colic reservoirs • Malignancies requiring removal of the bladder
• Severe haemorrhagic cystitis
• Incontinence
Metabolic acidosis (↑ Cl, ↓ bicarbonate,
azotaemia)
• Fatigue, anorexia, weight loss, diarrhoea,
polydipsia
• B12 and fat-soluble vitamin deﬁciency
• Diarrhoea, urinary calculi, cholelithiasis
Colon (ureterosigmoidostomy) • Children requiring diversion (extrophy, pelvic
radiation)
• No other bowel segment alternative
Metabolic acidosis (↑ Cl, ↓ bicarbonate,
azotaemia)
• Fatigue, anorexia, weight loss, diarrhoea,
polydipsia
• Pyelonephritis
• Adenocarcinoma at anastomotic site
Transverse colon conduit • Malignancies requiring removal of the bladder
• Small bowel not practical
Metabolic acidosis (↑ Cl, ↓ bicarbonate,
azotaemia)
• Fatigue, anorexia, weight loss, diarrhoea,
polydipsia
• Pyelonephritis
• Adenocarcinoma at anastomotic site
Table 2 Ideal characteristics of a urinary reservoir.
Characteristic Comments
Low-pressure system Higher internal pressure in the reservoir may overcome the
external sphincter mechanisms that maintain continence.
Stores a functional amount of urine (ª500 mL)
Reliable, complete continence Detubularisation of intestinal
segments limits the ability to generate a peristaltic pressure
wave. These waves can contribute to incontinence.
Complete voluntary control of voiding
No absorption of urinary waste products by
the reservoir walls
Minimises the likelihood of metabolic complications.
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However, ureterosigmoidostomy is prone to detrimental upper
tract changes in patients over time, e.g.10 years [1,2]. In
addition, the mixture of faecal and urinary streams predisposed
patients to a higher risk of bowel adenocarcinoma [3,4]. Several
modiﬁcations of the ureterosigmoidostomy were developed to
decrease the signiﬁcant complication rate associated with the
procedure. The sigma rectum, or Mainz II pouch, consists of a
detubularised colon 6 cm both proximal and distal to the
rectosigmoid junction, where the ureters are then implanted in
a non-reﬂuxing fashion [5]. The objective of this pouch was to
create a low-pressure reservoir to protect the upper tracts,
although the risk of adenocarcinoma still remained.
Kock et al. [6,7] descried the use of an intussuscepted nipple
valve stabilised with permanent staples, whereupon the distal
rectal segment is then opened and patched with ileum to
lower reservoir pressure. This conﬁnes urine to a smaller,
distal segment of bowel and therefore controls the amount of
bowel to which the urine is exposed. The technique lowers the
risk of metabolic complications but the risk of tumour
formation remains [8]. The combination of these issues have
led most practitioners to avoid ureterosigmoidostomy as a
urinary diversion approach unless absolutely necessary.
Conduits
Conduits may be constructed using either colon or ileum.
However, ileal conduits have become the ‘gold standard’ for
incontinent diversion and indeed remain the procedure of
choice for patients with contraindications to continent
diversion. Ileal conduits are relatively easy and quick to create,
minimising the rate of postoperative complications. Typically,
the terminal 10–15 cm of ileum is preserved to maintain
adequate absorption of bile salts, vitamin B12, and fat-soluble
vitamins. The isolated segment of ileum used for diversion is
exteriorised through the abdominal wall, where it serves as a
passive conduit for urine to drain into an appliance. The
presence of a stoma and external appliance can negatively
aﬀect a patient’s body image. In patients with foreshortened
mesentery, e.g. obese patients, a Turnbull loop stoma may be
used [9].
Continent Cutaneous Diversions
Continent cutaneous reservoirs use a low-pressure pouch
constructed of detubularised bowel with a functional
mechanism designed to prevent involuntary eﬄux of urine
ﬂow. Reservoirs diﬀer based upon the type of valve mechanism
constructed, the type of catheterisable stoma created, and the
exact segment of intestine used. As such, many technical
variations exist, e.g. the Kock, Indiana, and Miami pouches. The
most obvious advantage for this diversion lies in its continent
nature, dispensing with the need for an external appliance.
However, it requires clean intermittent self-catheterisation
(CISC) through the stoma both to empty the reservoir and
irrigate retained mucus. The ability of the patient to be
technically able to catheterise the stoma over a lifetime cannot
be overemphasised. Although these diversions have been largely
supplanted by the orthotopic neobladder, they are still used
when continence is desired in the setting of non-functional
urethra or a positive intraoperative urethral margin obviating
the ability to perform orthotopic diversion.
Results have varied in diﬀerent institutions. Holmes et al. [10],
for example, reported on 112 patients undergoing a modiﬁed
Indiana pouch over a 14-year period in a single institution
series. In all, 90% of patients had complications, with
incontinence representing the most common (28%)
complication. In all, 58% of complications were related to the
eﬀerent loop of the pouch, including stomal stenosis in 15%
and diﬃculty with catheterisation in 10%. Other problems
included ureteroenteric anastomotic strictures (7%), gallstones
(26%), kidney stones (6%), stones within the pouch (10%), and
small bowel obstruction (5%). In all, 26 (21%) patients
required an open operation, while 39 (31.2%) required a
minimally invasive operation for treatment of their
complications.
Alternative pouch designs, particularly using the in situ
appendix as the continence mechanism and catheterizable
limb, have reported improved outcomes with a lower rate of
major complications [11]. Reports using this mechanism or its
modiﬁcations in previously irradiated patients suggest that
improved outcomes can be achieved using appropriate design
alterations [12,13].
Orthotopic Neobladders
Orthotopic neobladders represent internal reservoirs
connected to the native urethra that rely upon the external
striated sphincter for continence. Reservoirs are typically
constructed from detubularised small bowel and then
anastomosed to the native urinary outﬂow tract.
Orthotopic neobladders were initially limited to men, as
women were thought to have an increased risk of local
recurrence and voiding dysfunction with orthotopic diversion.
However, with experience and improved understanding of the
female rhabdoid sphincteric mechanism, orthotopic diversion
has become more common in women, becoming the
procedure of choice for most patients after RC [14,15].
However, appropriate patient selection is critical to the success
of orthotopic diversions. It should not compromise the
cancer control of a potentially curative surgery, and it is
contraindicated if the urethra is non-functional or involved
with tumour. Like continent cutaneous diversions, orthotopic
neobladders require active patient participation to ensure
proper maintenance of the reservoir. If medical or
psychosocial issues preclude this level of cooperation, the
patient may be better served by an incontinent ileal loop
diversion.
Urinary diversion after radical cystectomy for bladder cancer
© 2013 BJU International 13
Role of Anti-reflux Mechanisms
Some urinary diversions, e.g. the hemi-Kock pouch, use an
anti-reﬂux mechanism to limit backﬂow of urine from the
reservoir into the upper urinary tracts. Although this
approximates the physiological anti-reﬂuxing state of the
native bladder and ureters, the need for anti-reﬂuxing
anastomoses in urinary diversions is controversial. Proponents
cite the detrimental upper tract changes seen in patients 10
years after creation of either freely reﬂuxing ileal conduits or
ureterosigmoidostomy [1,2]. However, it should be noted that
reﬂux-associated complications with orthotopic neobladders
have been predominantly seen in patients with high-
pressure reservoirs; contemporary neobladder designs use
detubularised bowel segments conﬁgured to provide low
ﬁlling pressures. In addition, some neobladder designs, e.g. the
Studer reservoir, use a long isoperistaltic proximal limb, which
provides resistance to retrograde ﬂow and therefore additional
anti-reﬂux protection [26]. Finally, non-reﬂuxing anastomoses
may be prone to a greater risk of complications, e.g. stricture,
ischaemic ﬁbrosis of the anti-reﬂux valve, or stone formation
from staples used to construct the valve system. For example,
in a randomised trial of 60 patients undergoing orthotopic
neobladder diversion, construction of a non-reﬂuxing
anastomosis was associated with a higher incidence of
anastomotic strictures (10%) and secondary impairment of
renal function compared with those with direct anastomoses
[20].
Functional Outcomes
The functional goals of an orthotopic neobladder are to
maintain day- and night-time continence and to allow
consistent emptying of the neobladder without the need for
CISC, while preserving renal function. Formal comparison of
functional outcomes data is complicated by variability in the
deﬁnition of continence, method of assessing continence, and
timeframe of assessment relative to surgery.
In several large series comprised predominantly of men, day-
and night-time continence rates ranged from 87 to 100%,
and 70 to 95%, respectively (Table 3) [16–25]. In general,
continence rates improve gradually postoperatively as the
neobladder volume increases, with maximum control of voiding
usually requiring several months. The Copenhagen group, for
example, reported night-time continence rates of 75% at 1 year
and 94% at 3 years, respectively, in a series of 166 patients [20].
Daytime continence also returns more rapidly than night-time
continence [19,22]. The number of patients reporting
simultaneous day- and night-time continence is lower, ranging
from 12 to 58% (Table 4) [4,28–31].
Inadequate emptying of the neobladder in men is uncommon.
The frequency and aetiology of this complication was
illustrated in a single institution series of 655 men reported by
Simon et al. [27]. Incomplete emptying, deﬁned by a residual
urine volume of >100 mL, was observed in 75 (11.5%) cases.
This was due to mechanical obstruction, i.e. benign strictures
of the neovesicourethral anastomosis or local tumour
recurrence, in 52 (7.9%) patients. Of these, 14 patients
required long-term catheterisation, while the remainder were
able to resume complete bladder emptying after endoscopic
management. Of the 23 (3.5%) cases without a mechanical
obstruction, failure of bladder emptying was due to
dysfunctional voiding, requiring CISC or indwelling
catheterisation.
Daytime continence rates range from 75 to 93% in women
at average follow-ups of 20–33 months; night-time rates
were also similar to men at 72–84% (Table 4) [32,33].
One signiﬁcant diﬀerence seen in women has been the
Table 3 Functional studies in men undergoing RC and orthotopic reconstruction.
Reference Number of
patients
(% male)
Median
follow-up,
months
Continence rate CISC
needed (%)
Day, % Night, % Time of
assessment*,
years
Barre, P; 1996 [16] 110 (100) 32 93 74 NR 1
Cancrini, A; 1996 [17] 96 (93) 28 98 74 1 NR
Elmajian, D; 1996 [18] 295 (100) 42 87 86 1 8
Hautmann et al. 1999 [19] 363 (100) 57 96 95 NR 6
Steven et al. 2000 [20] 166 (100) 32 98 80 3 NR
100 95 5 NR
Abol-Enein, H; 2001 [21] 450 (78) 38 93 80 NR NR
Madersbacher et al. 2002 [22] 176 (100) 95 92 70 5 NR
Carrion, R; 2004 [23] 138 (82) 41 91 70 NR 12
Sevin, G; 2004 [24] 124 (100) NR 92 90 4 NR
Stein, J; 2004 [25] 209 (81) 33 87 72 NR 25**
Total number 2127
(92%)
93 83
NR, not reported; *Time point at which all patients were assessed after surgery; **20% of men and 43% of women.
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phenomenon of hypercontinence, leading to urinary retention.
This is thought to be due in part to a posterior prolapse of the
neobladder during Valsalva voiding. This has resulted in an
increased need to perform CISC, ranging from 11 to 70%.
Techniques that have improved the anterior and posterior
support of the neobladder have led to improved functional
outcomes [34].
HRQOL
One of the primary reasons for selecting a continent diversion
lies in the preservation of ‘normal’ body image.While some
reports have noted improvements in various speciﬁc aspects
of HRQOL, e.g. body image, with these reconstructive
techniques, few formal studies have documented an
improvement in overall HRQOL. In fact, most studies have
failed to conﬁrm superior outcomes in patients undergoing
orthotopic as opposed to other forms of diversion. For
example, the Vanderbilt group analysed RAND 36-Item Health
Survey (SF-36) and Functional Assessment of Cancer
Therapy-General (FACT-G) questionnaires from 29 patients
with an ileal loop conduit compared with 42 with orthotopic
neobladders [35]. Although there were advantages in HRQOL
for those receiving an orthotopic neobladder, these patients
were younger, and the diﬀerences could have been age-related.
In addition, a systematic overview conducted by the University
of California, Los Angeles (UCLA) group examined HRQOL
after RC and urinary diversion for bladder cancer [36]. Of the
15 published studies, examined, none were randomised; only
one of which was prospective in nature. The authors
concluded that insuﬃcient data were available to conclude that
any one form of urinary diversion was associated with a better
HRQOL. The authors identiﬁed the lack of preoperative
baseline assessment, the lack of longitudinal studies using
valid and reliable measures, and the absence of a validated
instrument to measure bladder cancer-speciﬁc HRQOL, as
major limitations of currently published studies.
Factors Influencing Choice of Procedure
The primary goals in selecting a urinary diversion are to
provide the lowest potential for complications and the highest
HRQOL, while allowing for the timely completion of
chemotherapy and therapeutic goals. The decision process is
complex and involves consideration of issues related to cancer
stage, patient comorbidities, treatment needs, and patient
desires related to HRQOL (Table 5).While patient preference
is important, absolute and relative contraindications for the
use of various bowel segments and continent urinary
reservoirs do exist (Table 6). Patients should be informed that
intraoperative ﬁndings may dictate a change in the planned
form of urinary diversion, e.g. positive urethral margin
precluding orthotopic diversion. Even when an orthotopic
neobladder is planned, all patients should have a stoma site
marked preoperatively by an enterostomal therapist in the
event that orthotopic diversion becomes unfeasible.
Surgical and Oncological Considerations
for the Lower Urinary Tract
The primary goal of RC for bladder cancer is control of
the underlying tumour, and eﬀective resection must be
the highest priority. Disease extent and anatomical
considerations can therefore limit reconstructive options.
Table 4 Functional outcomes in women undergoing RC and orthotopic reconstruction.
Reference Number
of women
Median
follow-up,
months
Continence
rate, %
or n/N
Catheterisation,
% or n/N
Continent during
day and night,
% or n/N
Ali-el-Dein, B; 2002 [4] 60 20 93 84 14
Arai, Y; 1999 [28] 12 33 10/12 6/12 4/12
Hautmann, R; 2000 [29] 42 NR 86* NR 47
Stenzl, A; 2001 [30] 102 24 82 72 12
Stein, J; 2002 [31] 88 30 75–78*,** NR 44–58**
NR, not reported; *Percentage of patients reporting continence both during the day and at night; **Range based on chart review and patient questionnaire.
Table 5 Issues affecting urinary diversion selection.
Cancer control General health Technical HRQOL
Risk of local recurrence Functional status Functioning urethra Compliance
Previous pelvic radiation Previous surgeries Tumour location Sexual function
Need for adjuvant therapy Renal/hepatic function Ability to catheterise Body image
Secondary malignancies Medical comorbidities Mesentery length Urinary function
Urethral or bladder neck involvement Status of gastrointestinal tract Bowel condition Family support
Body habitus Operative duration Daily maintenance
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It is therefore critical to have an honest and informed
discussion with patients preoperatively about the risks and
beneﬁts of all forms of urinary diversions in this context.
The reported incidence of urethral recurrence after RC ranges
from 0 to 18%, with a recent meta-analysis reporting an 8.1%
overall incidence [37–40]. Most recurrences are detected 2
years after RC, although late recurrences have been reported.
Regular follow-up of the retained urethra is therefore
recommended.
Several risk factors have been associated with urethral
recurrence after RC, including multifocal disease, carcinoma in
situ, upper tract urothelial carcinoma, and involvement of the
bladder neck or prostatic urethra [41–43]. In men, one of the
most important risk factors for urethral recurrence appears to
be prostatic stromal invasion [37]. The University of Southern
California group reported a 5 year probability of urethral
recurrence of 6% for patients without prostatic involvement
vs 15% for patients with superﬁcial involvement vs 21% for
those with stromal invasion of the prostate [44]. However,
transurethral prostatic biopsy results do not always correlate
with ﬁnal pathology [45]. In addition, lower than expected
urethral recurrence rates have been reported in patients who
were orthotopically reconstructed despite involvement of
the prostate. Thus, routine preoperative prostatic biopsies
are no longer recommended and instead, intraoperative
frozen sections of the distal urethral margin have been
recommended before proceeding with an orthotopic
neobladder [46,47].
In women, bladder neck involvement is associated with a
higher incidence of urethral recurrence and therefore
represents an absolute contraindication to orthotopic
diversion [46,48,49]. Nonetheless, 50% of woman with
supposed bladder neck involvement have no pathological
evidence of urethral involvement after urethrectomy. Some
investigators have proposed using an intraoperative frozen
section of the urethral margin to determine whether an
orthotopic reconstruction is possible [47]. However, the
decision to perform an orthotopic diversion in a female with
tumour at the bladder neck should not be taken lightly, as
urethral recurrence in a female is equivalent to a pelvic
recurrence, leading eventually to death. Furthermore, some
women will have periurethral gland involvement on ﬁnal
pathology despite negative urethral biopsies [19,50].
The management of urethral recurrence after RC remains a
total urethrectomy, including excision of the meatus.We
follow patients with urinary cytology with either voided or
urethral wash cytology depending on the diversion and
cystoscope, and any patient with urethral-related symptoms,
abnormal discharge, or haematuria.
Locally advanced bladder cancer and/or regional node-positive
disease initially represented an absolute contraindication for
a continent cutaneous or orthotopic urethral diversion for
fear of diﬃculty in treating a local recurrence or giving
chemoradiation with a urinary reservoir. Ileal conduits became
the preferred diversion in this situation because of the
potentially quicker recovery time and lower risk of
perioperative complications. Nonetheless, continent diversions
have been used successfully in carefully selected patients.
Hautmann and Simon [50] reported on patients with locally
advanced bladder cancer who underwent an orthotopic
neobladder reconstruction, among which 17 (43%) had
concomitant distant metastases. In all, 36 (91%) patients
died from disease, three (8%) from chemotherapy related
complications and one (3%) from unknown causes. In all, 40
(93%) patients maintained satisfactory neobladder function
until death. Local recurrence compromised the upper urinary
tract, neobladder, and intestine in 24, 10, and seven cases,
respectively, but removal of the neobladder was only required
in one case due to enterovesicular ﬁstula. Another
treatment-related concern with continent diversion relates to
chemotherapy. The start of adjuvant chemotherapy may be
delayed due to the higher complication rate seen with
continent diversions, although data are limited about the exact
proportion of patients who experience delay [51]. In addition,
the toxicity of chemotherapy can potentially be increased from
the longer dwell time of urine in the reservoirs, although this
has been addressed by the use of both increased hydration and
the insertion of an indwelling catheter during active treatment
infusion [52]. Overall, urinary diversion with neobladder
construction can be considered in selected patients with
regional metastases or locally advanced disease, as few such
patients will probably have complications that disrupt
neobladder function. However, short life-expectancy and/or
an inability to perform CISC represent contraindications to
orthotopic reconstruction [53].
An uncommon but important complication involves the
possibility of secondary malignancy associated with the urinary
diversion itself. Speciﬁcally, all urinary diversions using bowel,
with or without separation of urine and faeces, may carry a
higher risk for intestinal tumour development compared with
the general population [3,4,54]. However, the median latency
Table 6 Absolute and relative contraindications for continent
cutaneous/orthotopic neobladder urinary diversions.
Absolute contraindications Relative contraindications
Impaired renal function Associated comorbid conditions
Impaired hepatic function Advanced age
Physical or mental impairment
to perform CISC
Need for adjuvant chemotherapy
Positive apical urethral margin
(for neobladder)
Prior pelvic radiation
Unmotivated patient Bowel disease
Urethral pathology
Extensive local disease with soft tissue
extension and high risk of local
recurrence
Review
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period is long at 10–13 years. Although the frequency of
malignancy is higher after ureterosigmoidostomy than with an
ileal conduit or continent diversion, long-term follow-up of
large cohorts will be needed to estimate the incidence of
such cancers with newer conduits and reservoirs [55,56].
Patients undergoing urinary diversion, particularly
ureterosigmoidostomy should therefore undergo regular
colonoscopic surveillance starting between 5 and 10 years after
surgery [57–59].
Other Considerations for The Upper
Urinary Tract
The upper urinary tract is also at risk of physiological
deterioration in up to 60% of patients [60]. This occurs usually
from infection, stones, lack of ureteric motility, or obstruction at
the ureteroenteric anastomosis. This has resulted in 6% of
patients with ileal conduits ultimately dying of renal failure, for
example [61]. It is of note diﬃcult to discriminate whether
abnormal renal units that were present before urinary diversion
caused the subsequent renal deterioration or whether the
deterioration occurred due to the intrinsic abnormality for which
the urinary diversion was created.
Patients with urinary diversions are also prone to bacteriuria
and developing pyelonephritis [62]. Up to 17% of patients
with conduits experience acute pyelonephritis, with a 4% death
rate from sepsis. Interestingly, deterioration of the upper tracts
appears more likely when urine cultures are positive for
Proteus or Pseudomonas [63]. Up to 12% of patients with
urinary diversions are also at risk of developing renal calculi,
due to hyperchloraemic metabolic acidosis, pre-existing
pyelonephritis, and/or UTI with a urea-splitting organism
[62,64].
Urinary Continence and/or Voiding
Dysfunction
Continent Cutaneous Diversion
The reported rates of incontinence for patients with continent
cutaneous diversions vary signiﬁcantly depending upon the
criteria used to deﬁne incontinence and the diﬀerences in the
duration of follow-up [10,33,65–67]. Day- and night-time
continence rates with continent cutaneous reservoirs range
from 90 to 98% [68,69].
The most frequent and troublesome long-term complication
associated with continent cutaneous diversions involves the
eﬀerent limb and catheterizable stoma. The reported rate of
stomal stenosis and diﬃculty in catheterising the stoma is
4–15% [10,67].
Incontinence with a continent cutaneous diversion can be due
to uninhibited pouch contractions, poor pouch compliance, or
an incompetent continence mechanism. Pouch urodynamics are
helpful in categorising the cause of the incontinence. Patients
with a poorly compliant, high-pressure reservoir may beneﬁt
from an initial trial of anticholinergics; refractory cases usually
require reservoir augmentation to decrease pressure and
increase capacity [70–72]. Incontinence secondary to
incompetent continence mechanisms usually require open
revision. Minimally invasive approaches, such as injecting
bulking agents, can be helpful for appropriately selected, mild
cases of incontinence.
Orthotopic Neobladder
The lack of uniformity in deﬁning voiding dysfunction and
incontinence, the often retrospective nature of assessment, and
the lack of validated instruments for measurement in orthotopic
neobladder series limit the ability to assess voiding dysfunction
after orthotopic diversion.A recent meta-analysis of >2000
patients showed a 4–25% rate of CISC for incomplete emptying
[32]. Daytime incontinence was present in ª13% of patients. The
rate of nocturnal incontinence is usually higher due to lack of the
guarding reﬂex from loss of the native bladder and is in the range
of 15–40%.
A unique aspect of voiding dysfunction should be considered
in women undergoing orthotopic reconstruction. Clinical
experience has suggested that 16–25% of women choosing
orthotopic reconstruction eventually experience urinary
retention [15,34,73,74]. Possible mechanisms for this
include mechanical kinking of the pouch at the posterior
pouch-urethral junction. Herniation of the pouch wall
through the prolapsed vaginal stump has also been proposed
as a possible mechanism for retention [34]. Technical
modiﬁcations, e.g. increased back-support of the pouch
through omental packing behind the reservoir, suspension of
the vaginal stump to the preserved round ligaments, and
suspension of the reservoir dome to the back of the rectus
abdominus muscles, have been proposed to reduce the
incidence of urinary retention.
Psychosocial and Medical
Considerations
Multiple factors need to be considered when choosing the
appropriate procedure for an individual patient. In choosing
the appropriate procedure, the patient and his family should
have realistic expectations about the outcome associated with
each reconstructive option. They should also understand
the eﬀorts that will be required on their part during the
rehabilitation process. In addition, patients must have
suﬃcient manual dexterity to master CISC, if the decision is
made to proceed with a continent diversion. An enterostomal
nurse specialist can be invaluable in educating the patient and
family and assisting with the decision-making process [75].
Advanced age can complicate both the operative procedure
and subsequent recovery [76]. Age has been associated with
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higher postoperative complication rates, but disease-speciﬁc
survival rates are similar [77–79]. As such, elderly patients are
usually oﬀered primarily ileal conduits, whereas orthotopic
neobladders tend to be reserved for younger, healthier patients
[80,81]. Elderly patients need to also be counselled that the
recovery of continence may take longer than in younger
patients. For example, Madersbacher et al. [22] found that age
is an important determinant of long-term reservoir capacity,
nocturia, and continence status in patients with ileal
neobladders. Similarly, Hautmann et al. [82] reported that
continence status at the 5-year follow-up approached 100% in
patients aged < 50 years but only 90% for those aged > 60
years. One of the explanations for this diﬀerence may be
decreasing external urethral sphincter function with age or the
decreased vigilance of elderly patients towards incontinence
[82,83]. Nonetheless, experienced centres have reported
continence rates of >90% daytime and >80% night-time
continence in properly selected patients [84]. However, it
should be noted that physiological age appears to be more
relevant to patient outcome, and it is therefore recommended
that no formal chronological age limit should be applied
[85,86]. Rather, patient selection as determined by surgical
ﬁtness, motivation, and functional status is more appropriate.
Our policy is to oﬀer continent diversions to older patients if
they are healthy and motivated enough to care for the
diversion. If an older patient becomes incapacitated and
unable to care for the continent diversion, then an indwelling
Foley catheter may be placed into the diversion similar to
what might be done for the native bladder.
Obesity can also increase the technical diﬃculty of RC and
complicate orthotopic neobladder construction [87]. However,
the postoperative management of an ileal loop conduit or a
continent reservoir is also more diﬃcult in the obese patient,
and thus most surgeons therefore do not consider obesity to
be a contraindication to reconstruction with an orthotopic
neobladder [88]. Many, including the authors, feel that
reconstruction to the urethra may be the least complicated
reconstructive option for the obese patient. However, obesity
may be associated with a higher incidence of a thickened
foreshortened mesenteric root, which can increase the
diﬃculty of bringing an orthotopic urinary diversion inferiorly
to the native urethra.
Urologists should ﬁnally be aware that adequate renal
function is required for the creation of any continent
diversion. Continent diversion imposes an extra metabolic
burden upon the kidneys, as urinary excretion products are
resorbed through the mucosal surface. Typically, only mild
metabolic abnormalities will be seen in patients who have
normal renal function. However, for those patients with
more severe renal dysfunction (serum creatinine values of
>2.0–2.5 mg/dL or 180–230 mM/L or estimated GFR of
<40 mL/min/1.73 m2), an ileal loop conduit is preferred over
the continent alternatives.
Complications
Surgery Related Complications
Considerable variability exists in the reported early and
long-term morbidity rates after urinary diversions. Morbidity
rates 30 days after surgery range between 20 and 56%, while
long-term morbidity >30 days ranges from 28 to 94%
[22,65,89]. Diversion-related complications are speciﬁc to the
type of diversion and are generally categorised into those
involving the bowel anastomosis, those related to the type of
reservoir/conduit, and those associated with the ureteroenteric
anastomosis [33].
Ileal conduits
The ileal conduit is often chosen for patients with signiﬁcant
medical comorbidities in an eﬀort to minimise postoperative
complications. Because of the greater prevalence of risk factors
in patients selected to undergo ileal conduit diversions, the
rate of surgical complications still approaches that of
continent diversions performed in healthier patients. None
of the comparative studies control for the diﬀerences in
comorbid status, and one can therefore assume that
complication rates would be further increased if ‘sicker’
patients underwent continent diversion.
The overall rate of complications associated with conduits is
similar for ileum and colon segments among properly selected
patients [22,60,95,96]. The four most common complications
reported are pyelonephritis in 5–23%, ureteric obstruction in
2–22%, urinary calculi in 3–16%, and stomal complications in
2–62% of cases in a series of 412 patients with a median
follow-up of 98 months [22,60]. The frequency of complications
increased over time from 45% at 5 years to 94% at >15 years.
The most frequent complications reported were renal
insuﬃciency in 27%, stomal problems in 24%, bowel problems
in 24%, UTIs in 24%, ureteric obstruction in 14%, and urinary
calculi in 9%. The impact of these complications upon
patients can be signiﬁcant. Renal insuﬃciency leads to
impaired clearance of drugs and medications. Complications,
e.g. stomal stenosis, can exacerbate renal failure and require
revision surgery. Small bowel obstruction may require
conservative measures, such as nasogastric tube drainage, or
more aggressive treatments, such as exploratory laparotomy
and bowel resection. Ureteric obstruction may necessitate
placement of stents or nephrostomy tubes, endoscopic
treatment of strictures, or surgical revision of ureteroenteric
anastomoses. The presence of urinary calculi may require
lithotripsy and stent placement.
Continent cutaneous diversions and orthotopic neobladders
Continent urinary diversions involve multiple suture lines,
valve mechanisms, tapered limbs, and longer operative times
than ileal conduits. As such, they are subject to a higher
incidence of urinary leaks in the early postoperative period
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and may be subject to pouch rupture at any time. Pouch
rupture is treated initially with conservative measures, e.g.
catheter drainage. If the urinary stream needs to be diverted
further, nephrostomy tubes can be placed. If these measures
still prove insuﬃcient, surgical revision of the urinary
diversion can then be performed.
The complications seen with continent urinary diversions
diﬀer in the early postoperative period compared with those
seen in the long-term and are speciﬁc to the type of reservoir
(Tables 7 and 8) [10,19,20,33,60,65–67,90–94,96]. If one
combines the reported percentage of early and late
complications in large institutional series associated with each
procedure, the risk of having a signiﬁcant complication over
the lifetime of the patient is 18–36% for continent cutaneous
reservoirs and 10–18% for orthotopic neobladders.
Diminished Renal Function
Compromise of renal function over time may be seen in
patients after urinary diversion. The development of
urinary tract obstruction at the site of anastomosis or
reservoir/conduit outﬂow, stones, and chronic infection
represent contributory factors. However, it is not clear whether
the loss of renal function exceeds that expected in an ageing
population, as kidney function also naturally gradually
deteriorates in the elderly even in the absence of urinary tract
surgery [52]. Careful surveillance for evidence of obstruction
or stone formation will allow for prompt intervention and
may prevent loss of renal function.
Infection
Infectious complications can contribute to acute morbidity
and chronic renal insuﬃciency. Contributing factors include
the use of intestinal segments normally colonised with
bacteria, incomplete emptying leaving residual urine as a
nidus for infection, and the use of CISC that introduces
bacteria into the urinary reservoir. Although the presence
of small bowel intestinal mucosa appears to promote
asymptomatic bacterial colonisation, urosepsis rarely occurs
unless the patient has recurrent UTIs. This was shown in a
series of 66 patients with orthotopic neobladders reported by
Wood et al. [97]. Asymptomatic bacteriuria was seen in 78% of
the 55 patients who voided through an orthotopic neobladder,
but only 39% of patients developed symptomatic urinary
Table 7 Comparison of complications in ileal conduits vs continent diversions.
Type of diversion Reference No. of patients Time from surgery, months % Complications
Ileal conduit Parekh et al. 2000 [66] 81 19 22
Gburek et al. 1998 [90] 66 20 18
Madersbacher et al. 2003 [60] 131 98 66
Continent diversion Parekh et al. 2000 [66] 117 20 12
Gburek et al. 1998 [90] 66 17 18
Shimogaki et al. 1999 [91] 8 59.9 0
Mills et al. 2000 [92] 15 19 13
Ali-el-dein et al. 1999 [93] 60 20.2 13
Hautmann et al. 1999 [19] 363 57 15.4–23.4*
Steven et al. 2000 [20] 166 32 23.5–37.4*
Studer et al. 1997 [94] 200 30–134 12–22*
*Early (90 days) vs late (>90 days) complications.
Table 8 Early vs late complications in continent urinary diversions.
Complication type Early (≤30 days) % Long term (30 days to death) %
Reservoir-related Urinary leak 1.8–10
Pyelonephritis 0.9–13 Pyelonephritis 3–10
Upper tract calculi 3
Pouch calculi 5–35
Anastomosis-related Ureteric obstruction 0–6.3 Ureteral obstruction/stricture 2–30
Urethral or stomal stricture 2–14.3 Renal deterioration 0.4–10.5
Ureteric reﬂux <2
Bowel-related Faecal leak 1–2 Metabolic abnormalities 15–50
Prolonged ileus 2–11 Bowel obstruction 4–8
Other Wound infection 5
Wound dehiscence 5 Incisional hernia 0–10
Deep venous thrombosis 2–2.7 Deep venous thrombosis 0–6.3
Loss of continence mechanism 15–20
Hypercontinence (male vs female) 3–9 vs 10–50
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infection. Urosepsis rarely occurred, except in the context of
recurrent UTIs. Thus, patients do not require chronic
suppressive antibiotic therapy unless a history of recurrent
UTIs exists. Those with acute infections should be treated with
appropriate antimicrobial therapy for limited periods only.
Nutritional and Metabolic Abnormalities
Resection of an ileal or colonic segment of bowel may result
in malabsorption of bile salts [98]. This can lead to lipid
malabsorption and gallstone formation. However, the ileal
segments used for urinary reconstruction are generally
short enough to avoid this problem. For example, in one
observational study of 114 patients without a history of
symptomatic gallstone disease or previous cholecystectomy at
the time of urinary diversion, 10% of men and 25% of women
developed gallstones, an incidence consistent with that
normally expected in the American population [99].
Resection of the ileum can also lead to inadequate absorption
of the vitamin B12 intrinsic factor complex. Vitamin B12
deﬁciency may therefore ensue, manifested as either
megaloblastic anaemia or with neurological symptoms. The
incidence of vitamin B12 deﬁciency after urinary diversion is
unclear; long-term estimates range from zero to as high as
33% at 5 years after surgery [19,20]. This variability may be
due to the diﬀerent methods of testing for vitamin B12
deﬁciency (e.g. the Schilling test, serum vitamin B12 levels,
methylmalonic acid and/or homocysteine levels, or overt
megaloblastic anaemia), as well as diﬀerences related to the
length and section of ileum used for the urinary diversion
[100,101]. The authors recommend that vitamin B12 levels be
monitored annually beginning 3–5 years after diversion and
that patients be evaluated for symptoms consistent with
vitamin B12 deﬁciency. Replacement therapy should be
initiated as needed.
Electrolyte abnormalities may also result from the
reabsorption of excreted metabolites. For example,
ureterosigmoidostomy and diversions using the ileum and
colon can result in severe hyperchloraemic hypokalaemic
metabolic acidosis, although the severity of the acidosis is
lessened in newer reconstructive procedures that limit the
amount of time that urine is in contact with bowel mucosa
[98]. For example, a contemporary series of 363 men with ileal
neobladders reported by Hautmann et al. [19] reported only a
1% rate of severe metabolic acidosis, although nearly one-half
of all patients required some form of alkalinizing treatment
due to mild acidosis. Hyperchloraemic hypokalaemic
metabolic acidosis is typically treated using sodium
bicarbonate (NaHCO3). In contrast, jejeunal diversions can
result in hypochloraemic hypokalaemic metabolic acidosis,
best treated using sodium chloride (NaCl), chlorpromazine, or
nicotinic acid. Regardless of the type of diversion created,
regular monitoring of electrolytes with each follow-up visit
will allow for the timely institution of appropriate corrective
therapy as needed.
Conclusions
Urinary tract reconstruction after RC represents a complex
process that attempts to maximise HRQOL for patients after
surgery. In appropriately selected patients, the creation of an
orthotopic neobladder permits the elimination of an external
stoma and preservation of body image without compromising
cancer control. However, the patient must be fully educated
and committed to the labour-intensive rehabilitation process.
He must also possess adequate manual dexterity to perform
CISC when necessary.When involvement of the urinary
outﬂow tract by tumour prevents the use of an orthotopic
neobladder, a continent cutaneous reservoir may still oﬀer
substantial advantages in terms of preserving body image
over an incontinent ileal conduit. For patients who are not
candidates for either type of continent diversion, the ileal loop
remains an acceptable and reliable option.
The choice of urinary diversion involves many diﬀerent
factors. It appears that HRQOL diﬀerences mainly stem from
preservation of body image, particularly with orthotopic
neobladders. More detailed analysis of HRQOL diﬀerences
will require prospective studies with adequate baseline
measures using validated instruments. It is important to note
that each type of urinary diversion comes with potential
complications, ranging from speciﬁc metabolic and nutritional
abnormalities to infection, bowel obstruction, renal
deterioration, and pouch rupture. One must always be vigilant
for urethral recurrence in orthotopic reconstruction, which
carries a poor prognosis for patients.
The ideal urinary diversion should successfully preserve renal
function while managing urinary outﬂow and minimising
morbidity to the patient. Much progress has been made in the
ﬁeld of urinary reconstruction since the introduction of
ureterosigmoidostomy. Newer urinary diversions are able
to decrease the risk of secondary malignancy, provide
continence, and preserve body image to a much greater extent.
However, the quest for further improving urinary diversion
continues in an eﬀort to beneﬁt patients.
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